An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms.

Trial Profile

An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 12 Sep 2012

At a glance

  • Drugs Vigabatrin (Primary)
  • Indications Infantile spasms
  • Focus Pharmacokinetics
  • Sponsors Lundbeck Inc
  • Most Recent Events

    • 12 Sep 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
    • 08 May 2012 Planned initiation date changed from 1 Apr 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 17 Feb 2012 Planned initiation date changed from 1 Jan 2012 to 1 Apr 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top